Live symbol workspace

HIMS market intelligence

Chart context, AI evidence, sentiment, related news, and verified outcome history are grouped into one asset dossier.

Current $19.15

Trend Flat

Sentiment Neutral

{# Only render the live technical grid when the AI analysis carries real, non-placeholder data. Sentinel payloads (data_status error/collecting, current_price 0) are handled by the Asset Intelligence Dossier below, which degrades to a calm branded empty state instead of "0%" widgets. #}

Detailed Market Analysis

Key Levels

Support

$18.19

Resistance

$20.11

Volume & Momentum

Volume

Weak

0.8x avg

Momentum

0%

Weak

Technical Context

Current price

$19.15

RSI context

50

Market Sentiment

50

Neutral

Stock Metrics

Daily Vol

0%

VIX Est

20

Weekly

0%

Asset Intelligence Dossier

Over the last 30 days, AI sentiment for HIMS skewed bearish (3 of 4 scored calls).

Provider track record

Not enough scored provider calls yet for this asset.

Confidence trend

30%

— 0.0 pts vs previous week

Avg confidence across 11 calls in the last 7 days

What sources say

Bearish 3 articles

S&P 500, Nasdaq end lower as inflation, Iran tensions weigh

Hims & Hers plummets 16% after first-quarter loss, weak earnings guidance

Hims Sales Miss on Rising Competition for Weight-Loss Drugs

Neutral 1 article

Earnings live updates: Plug Power, Hims & Hers set to kick off week of quarterly updates

Insider Trading

Insider	Role	Date	Type	Value
WELLS DAVID B	Director	May 26 '26	Buy	1172974.0
Okupe Oluyemi	Chief Financial …	May 18 '26	Option Exercise	39830.0
Okupe Oluyemi	Chief Financial …	May 18 '26	Sale	187916.0
Boughton Soleil	Chief Legal …	Apr 20 '26	Sale	283890.0
Okupe Oluyemi	Chief Financial …	Apr 20 '26	Option Exercise	108531.0
Okupe Oluyemi	Chief Financial …	Apr 20 '26	Sale	588615.0
Okupe Oluyemi	Chief Financial …	Apr 17 '26	Option Exercise	30982.0
Okupe Oluyemi	Chief Financial …	Apr 16 '26	Sale	956147.0
Okupe Oluyemi	Chief Financial …	Apr 17 '26	Sale	501158.0
Boughton Soleil	Officer	Apr 20 '26	Proposed Sale	283890.0

Source: FinViz — Data may be delayed

Technical Observations

Refreshing technical observations from FinViz...

HIMS News Intelligence (13 articles)

AI-curated news influencing HIMS price, sentiment, and trend

Explore All HIMS News with AI Analysis

Economy

3 weeks, 4 days ago

S&P 500, Nasdaq end lower as inflation, Iran tensions weigh

STORY: U.S. stocks ended mostly lower on Tuesday, but the Dow posted a modest gain, while the S&P 500 edged …

Impact on HIMS: The S&P 500 edged down slightly, while the Nasdaq lost 0.7%, as …

The S&P 500 and Nasdaq declined due to higher-than-expected inflation and ongoing Iran tensions, while … High (80%)

View full analysis →

Yahoo Finance 80% confidence

Stocks

3 weeks, 4 days ago

Hims & Hers plummets 16% after first-quarter loss, weak earnings guidance

Hims & Hers reached a deal with Novo Nordisk in March to sell its GLP-1 weight loss drug Wegovy on …

Impact on HIMS: May pressure downward momentum

Financial market analysis indicating bearish sentiment based on current trends. Medium (60%)

View full analysis →

CNBC 60% confidence

Economy

3 weeks, 5 days ago

Hims Sales Miss on Rising Competition for Weight-Loss Drugs

Hims & Hers Health Inc. reported a first-quarter loss and sales that missed Wall Street estimates amid increasing competition in …

Impact on HIMS: May pressure downward momentum

Financial market analysis indicating bearish sentiment based on current trends. Medium (60%)

View full analysis →

Bloomberg 60% confidence

Economy

3 weeks, 5 days ago

Earnings live updates: Plug Power, Hims & Hers set to kick off week of quarterly updates

The pace of first quarter earnings reports eases this week as economic data takes center stage, but investors will still …

Impact on HIMS: Neutral market sentiment indicated

Financial market analysis indicating neutral sentiment based on current trends. Medium (50%)

View full analysis →

Yahoo Finance 50% confidence

Economy

1 month, 2 weeks ago

Hims Yields Ground in GLP-1 Market. Why Its CEO Is Calling It the Netflix of Pharma.

Hims & Hers Health will allow providers to prescribe scripts filled by LillyDirect, Eli Lilly’s direct-to-consumer platform.

Impact on HIMS: Neutral market sentiment indicated

FinBERT analysis of financial text showing neutral sentiment with 94.1% confidence. High (94%)

View full analysis →

Yahoo Finance 94% confidence

Economy

1 month, 2 weeks ago

Stock Market Today, April 21: Hims & Hers Health Drops as Amazon Unveils Competing Weight Loss Program

Telehealth investors weigh Amazon’s new anti-obesity drug push against this platform’s recent rapid growth, today, April 21, 2026.

Impact on HIMS: Neutral market sentiment indicated

FinBERT analysis of financial text showing neutral sentiment with 94.1% confidence. High (94%)

View full analysis →

Yahoo Finance 94% confidence